Wright State University

CORE Scholar
Browse all Theses and Dissertations

Theses and Dissertations

2011

Utilization of a Custom-Designed Microbiota Array to Determine
the Distal Gut Microbiota of Healthy Human Adults
Richard Thomas Agans
Wright State University

Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all
Part of the Immunology and Infectious Disease Commons, and the Microbiology Commons

Repository Citation
Agans, Richard Thomas, "Utilization of a Custom-Designed Microbiota Array to Determine the Distal Gut
Microbiota of Healthy Human Adults" (2011). Browse all Theses and Dissertations. 1031.
https://corescholar.libraries.wright.edu/etd_all/1031

This Thesis is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It has
been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE
Scholar. For more information, please contact library-corescholar@wright.edu.

Utilization of a Custom-Designed Microbiota Array to
Determine the Distal Gut Microbiota of Healthy Human Adults

A thesis submitted in partial fulfillment of the requirements for
the degree of Master of Science

By

RICHARD THOMAS AGANS
B.S. Ohio Dominican University, 2008

2011
Wright State University

Wright State University

School of Graduate Studies
Date: Feb. 07, 2011

I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY
SUPERVISION BY RICHARD THOMAS AGANS ENTITLED Utilization of a CustomDesigned Microbiota Array to Determine the Distal Gut Microbiota of Healthy Human Adults
BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE
DEGREE OF Master of Science

__________________________
Oleg Paliy, Ph.D.
Thesis Director
__________________________
Barbara Hull, Ph.D.
Program Director, Microbiology and Immunology
M.S. Graduate Program
Committee on
Final Examination

_______________________
Oleg Paliy, Ph.D.

_______________________
Mill Miller Ph.D.

_______________________
Nancy Bigley Ph.D.

_______________________
Andrew T. Hsu, Ph.D.
Dean, School of Graduate Studies

Abstract
Agans, Richard Thomas. M.S., Microbiology and Immunology M.S. Program,Wright State
University, 2011. Utilization of a Custom-Designed Microbiota Array to Determine the Distal
Gut Microbiota of Healthy Human Adults

The human microbiota is an essential component of human health and disease. It is
involved in metabolism of dietary components and is at the forefront of the intestinal immune
response. Classical techniques applied to study intestinal microbiota illustrated higher presences
of aerobic and facultative-anaerobic bacteria, however; the levels of obligate anaerobes had been
underrepresented. Modern technologies based on DNA and RNA analysis have circumvented
previous challenges allowing researchers to gain more extensive insight into the complex
intestinal environment. In this work, a recently developed Microbiota Array was used to assess
intestinal microbiota of 10 healthy adults (age 22-61, ave. 34.3yrs). Class level results showed
dominance of Clostridia in all samples, encompassing approximately 74.0% of total class signal.
Little variation was seen among samples at the Class level, however, this variation increased at
the Genus level.

Ruminococcus was the most abundant genus (21.1%), followed by

Faecalibacterium (8.7%) and Papillibacter (6.8%). Members of 87 genera were detected in at
least one sample. Among these, most were present at low abundance levels (65 genera had
average abundance less than 1%). A core microbiome of 113 phylo-species was found in every
sample. Among these core phylo-species, Ruminococcus, Roseburia, and Papillibacter were the
major contributors. Overall, similar numbers of phylo-species were detected across samples
(294-385, ave. 330). The results here show that the Microbiota Array is an efficient and viable
method for analyzing the intestinal microbiota. In conclusion, this work solidifies the Microbiota
Array as a formidable tool in analysis and characterization of intestinal microbiota.
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1. INTRODUCTION
Microbiota
Microorganisms inhabit a plethora of environmental niches, from soil, water (salt and
fresh), air, and plant surfaces, to organisms such as insects, mammals, birds, reptiles, etc. [1].
There has long been much interest in studying this minute world of life, exemplified by the vast
number of studies conducted on microbiomes inhabiting environments within the human body
[1].

There have been numerous studies investigating the microbiota of human body niches [27]. Studies examining the skin microbiota of humans have shown variations between different
body niches. One such report by Costello et al. (2008) observed differences between the hands,
head, legs, arms, etc.; it was determined that microbiota inhabiting right and left sides of the
body tended to cluster together with the exception of index fingers which were more related to
each palm. These authors found differences across niches and attribute those differences to local
environmental characteristics of each skin area. These authors go on to discuss how bacterial
diversity relates to body habitats of the skin, gut, auditory, and oral tissue; and found that
diversity decreases from upper body skin habitats with gut, oral, lower body skin habitats and
auditory tissues following in that order. Human skin is covered with prokaryotic organisms,
Whitman et. al point out, “the density of prokaryotes is about 103-104 cells/cm2, except in the
groin and axilla where it is 106 cells/cm2. Based on an average adult human’s skin, the total
number of prokaryotes on the skin of an individual is about 3 X 108 cells” (1998). The observed
diversity in such niches could possibly be related to exposure to external environmental
conditions and stimuli. The community observed by Costello’s group consisted of the phyla
Firmicutes, Actinobacteria, Bacteroidetes, and Proteobacteria. The oral and stomach microbiota
have been shown to differ in composition compared with skin and gut microbiota, interesting
1

since the mouth has close proximity to the skin epithelium and stomach contents are sent through
the gut. One such study aimed at determining bacterial profiles in healthy oral cavities claimed
that of five sites sampled within the mouth there was a common presence of genera from the
classes Bacilli and Clostridia [7]. Interestingly, it was determined by culture-independent
techniques that Helicobacter pylori, a common gastric pathogen, is present in healthy stomachs;
however, the authors were unable to concretely determine whether this presence was due to
potential contamination, transient organisms, or cell remnants [6]. While these authors do indeed
show that H. pylori was present in their samples, the inability of being able to determine the
extent that potential contamination plays in this observation suggests that broad range polymerase
chain reaction (PCR) based approach is not advantageous.

The intestinal microbiota is responsible for processes including nutrient digestion of
dietary components, immune modulation, and pathogen resistance, among others [8]. It has been
estimated that the human intestine contains upwards of 1013 bacterial cells, with a combined
genome larger than that of the human host [1]. The data collected in these early studies indicate
the intestinal microbiota is integral part of human health and disease.

The Human “Super-Organism:” Symbiosis in the Intestinal Tract
A constant bacterial presence in the intestinal tract has resulted in a relationship between
the host and bacteria that is beneficial for both parties. This relationship is evidenced by the
presence of many bacterial cells at any given time in the intestinal tract without significant
immunological action or challenge. Therefore, there must be symbiotic relationships allowing
these bacteria to be present in such numbers on a constant basis, and this symbiotic relationship is
found upon understanding the roles that microbiota play in human digestion.

It is well known

that most of the body’s metabolism and absorption of dietary components takes place in the
2

intestinal tract.

Bacteria are able to break down pectin, hemicelluloses, starches, cellulose and

other polysaccharides, the byproducts of which, can be used by the human host, along with other
bacterial species for biochemical processes [9-19]. This ability to break down certain dietary
products is specific to certain microbiota and is a result of complex evolution and gene transfer,
allowing for such abilities to be nonobligatory for the human host.

One example of such relationships comes from Xu et al. [20] who looked at two species
of intestinal Bacteroides and observed multiple instances of similar protein-coding genes being
inherited by the microbiome, proposing that these genes were laterally transferred due to the
genes differing composition from that of the bacterial genomes. The presence of genes found in
the Bacteroides species were shown to be involved in metabolism of plant polysaccharides and
proteins, as well as glycans associated with the intestinal epithelium mucous layer. The group
went on to suggest that there are two main forces driving the establishment of symbiosis in the
intestinal environment, a “top-down” selection via the host to produce a homogenous microbiome
with a “bottom-up” selection between microbes to produce a differentiated genome. These
selection processes result in a functional microbiota that has established symbiosis with the
human host.

Li et al. [21] were investigating relationships between microbiota structure with
metabolite Nuclear Magnetic Resonance (NMR) data. They employed denaturing-gradient gel
electrophoresis (DGGE) to differentiate bacterial groups, and NMR to assess urinary tract
metabolites. These authors reported correlations between groups detected through DGGE and the
NMR results. They suggested that their results would lay the groundwork for a “Rosetta Stone,”
to understand the intestinal microbiome and relations to human hosts. Along with these works
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there have recently been many others detailing symbiotic, evolutionary and, mutualistic
relationships between host and bacteria as well as between bacterial species [22-25].

These works begin to illustrate the vast significance of microorganisms in the human
host. To fully understand human health and disease, a proper knowledge of microbiota/host
relationships (cell-cell communication, bacterial numbers, activity, etc.) is needed.

Bacteria in the Intestinal Tract: Relations with Host and Each Other
Sghir et al. state that there are on average around 1011 bacterial cells for every gram of
fecal content. This statement is further solidified by Dethlefsen et al. who explain that microbes
inhabiting the colon outnumber human cells by 10-fold, and contain a combined total of 100-fold
more genes than that of humans. When breaking down the microbial community it has been
shown that the majority of this population is made up of the phyla Firmicutes, Actinobacteria, and
Bacteroidetes [4, 26].

Bacteria in the intestinal tract are involved in many processes and interactions with each
other and the human host as well. As a result of reactions between microorganisms and the host,
a person’s immune system has to deal with the sheer numbers of foreign and commensal
microorganisms. In response to the persistent presence of bacteria, albeit commensal, the human
immune system has developed mechanisms to keep bacteria in check. The immune system
maintains this balance through production of mucus, antimicrobial proteins, activation of immune
cells, and clearance of bacterial cells [27]. Goblet cells lining the epithelium produce mucus,
which serves two functions, 1) to act as an external layer to which bacteria bind, keeping them
from invading the simple epithelium, and 2) an internal layer containing a high concentration of
antimicrobial peptides, that act against bacteria upon contact [27]. Another mechanism by which
4

the human body recognizes bacteria (commensal/pathogenic) is through the binding of pattern
recognition receptors to bacterial cell wall components, triggering a downstream response to
produce antimicrobial proteins or activation of adaptive immune cells i.e. B and T cells.

The body is also proactive in the production of a certain class of antimicrobial peptides
known as defensins, more specifically the alpha-defensins. These defensins are constitutively
expressed and released into the lumen of the digestive tract. Upon recognition of bacteria
defensins, punch holes in the membranes of microorganisms, further keeping bacterial numbers
manageable [28-30].

These immune products represent only a small portion of the many

mechanisms that are involved in the human innate response to bacterial presence.

Along with the body’s response to bacterial stimulus, there also exists cross-talk between
bacterial cells in the intestinal tract. One such mechanism of cross-talk, known as quorum
sensing, allows bacterial cells to regulate expression of certain genes as a function of population
density [31]. Compounds called autoinducers, which can be produced by bacterial species of the
same genus or by those from an unrelated genus, are key in keeping communities fit by keeping
communities from growing beyond their ability to maintain themselves. This mechanism is
beneficial for the microorganism in relation to the immune response in that this sensing allows
the community to grow to a point that it is able to function and thrive without initiating an
immune response by growing too large [32]. The body is remarkable in the relationships it has
evolved with the intestinal microbiota, and this is only a small portion of the interaction between
microorganisms and the human intestinal systems; to go into more detail would be beyond the
scope of this literature.

5

As Pai and Kang explain, the intestinal microbiota is equipped to metabolize dietary
components unusable by the host until broken down into smaller constituents. These bacterial
species utilize nutrient sources including plant polysaccharides such as cellulose, xylan, and
pectin. They are also actively involved in absorption of lipids, recycling of nitrogen, production
of vitamins, etc. [33]. This is further explained for Bacteroides thetaiotaomicron, describing how
the bacterium has more than double the glycoside hydrolases as the human host along with eight
starch utilization genes. These authors also discuss the production of short chain fatty acids and
absorption by host cells; in a culminating statement the authors describe an “eating together”
relationship further illustrating symbiosis in the intestinal tract.

The evidence in these works

further suggest that the intestinal microbiota is crucial in proper homeostasis.

Major Intestinal Phyla
Although the intestinal microbiota contains more than 100 different bacterial genera,
encompassing more than 1000 different species, all these species are members of only a few
phyla. There are many publications that discuss the distribution of bacteria in the intestinal tract,
indicating that the phyla Firmicutes, Actinobacteria, and Bacteroidetes dominate the intestinal
microbiota [4, 26].

Notable among these phyla is the ratio between the Firmicutes and

Bacteroidetes, a ratio that has received attention from researchers. It appears that this ratio
“evolves” in connection with a person’s life. This ratio was seen to increase from infancy to
adulthood and then decrease again [34]. Further investigation into this ratio may potentially lead
to an alternative diagnostic approach for assessing intestinal disease.

Prominent Bacterial Genera in the Intestinal Tract
At the genus level, it has been shown that Ruminococcus, Bacteroides, and
Faecalibacterium are the most prominent. Of particular interest, is the genus Faecalibacterium;
6

which has been shown to aid in immune remediation of colitis, in addition to its involvement in
metabolism [19, 35]. Sokol et al. looked at Faecalibacterium prausnitzii in a trinitrobenzene
sulfonic acid (TNBS) model of colitis and observed that both in vitro and in vivo models resulted
in a decrease in colitis. This remediation was attributed to F. prausnitzii’s ability (through
production of metabolites) to induce IL-10 (anti-inflammatory cytokine) production, and decrease
production of both IFN-γ and IL-12 (pro-inflammatory cytokines). Along with the diminished
effects of the colitis model, F. prausnitzii was shown to rectify the dysbiosis that was created as a
result of said colitis [35]. This effect of Faecalibacterium is further solidified by reviewing
literature addressing the effects of butyrate on immune function which itself produces an antiinflammatory effect by increasing IL-10 production, along with this promotion of antiinflammatory cytokine stimulation it has been shown that butyrate decreases levels of
proinflammatory cytokines by inhibiting NFkB [36]. This organism has been shown to be a
prominent producer of butyrate in the normal diet as well as a major player in utilization of
acetate [19, 37].

The involvement of Bacteroides spp. in the intestine has been well documented [10, 11,
38-40]. The increased presence of Bacteroides in vegetarian diets is indicative of its ability to
hydrolyze plant polysaccharides, further evidenced by the prediction of 226 glycoside hydrolases
in Bacteroides thetaiotaomicron compared to 96 known hydrolases in the human genome [41].
This organism is also known to be efficient in its utilization of starches in the diet, containing
eight starch utilization genes which allows the organism to break down dietary starches into short
chain fatty acids such as acetate, butyrate and propionate; which can then be utilized by
Faecalibacterium, other microorganisms and human colonocytes [33, 37].

Aside from

Bacteroides spp. being a crucial component in proper nutrient extraction it is also known to be
important in proper development of the post-natal immune system [42]. It has been reported that
7

germ free mice, which do not contain a developed immune system, can have this lack of proper
immune function corrected through administration of either harvested microbiota from
conventional mice or Bacteroides thetaiotaomicron [42]. Their results are important because
they highlight the importance of microbiota members in maintaining proper intestinal health.

Another constituent of the intestinal microbiota is the genus Ruminococcus.
Ruminococcus spp. are part of the Firmicutes phylum , which has been shown to be one of the
major phyla in the human colon [38, 43, 44]. Ruminococcus species contain cellulolytic
complexes that enable these organisms to degrade plant cell wall polysaccharides, which is
essential for further processing of plant components [44]. A benefit of these complexes is the
allowance for Ruminococcus spp. to attach to the particle-phase of intestinal luminal content,
creating a close association between organism and nutrients further enabling propagation and
community formation [9, 44]. It has been documented that the Firmicutes phylum has higher
presence when characterizing particle-phase luminal content, which further suggests the role of
Ruminococcus spp. in the human diet in the essence that Ruminococcus spp. make nutrients
available for other bacteria which make energy sources for human colonocytes. [9, 38, 44, 45].
In fact, Abell et al. show that Ruminococcus bromii and related phylotypes were increased in
patients receiving a diet that was high in resistant starches [46].

Initial Colonization and Structure of the Intestinal Microbiota
Bacteria and other organisms do not spontaneously appear in the human gastrointestinal
tract, they must originate externally. Tlaskalova-Hogenova et al. state, “[s]tarting from the first
hours after the delivery from the sterile uterine environment…the interaction of the macroorganism with micro-organisms begins: the main portal of entry of microbes is skin and mucosal
surfaces of the gastrointestinal, respiratory and urogenital tracts.” [47] It is known that infants are
8

exposed to bacteria when contacting birth canal and mothers vagina upon delivery which results
in an infant exposure mainly to aerobic species [48]. Palmer et al. performed a study aimed at
determining a healthy microbial community structure in infants.

This study addressed two

aspects of microbiota interrogation by assessing not only the microbiota of newborns, but also
determining the difference in analysis through pyro-sequencing and microarray analyses. To
address the latter first, they were able to show that both microarray and pyro-sequencing gave
extremely similar results. These authors note that of all their obtained samples, two belonging to
a pair of twins delivered through caesarian-section, had relatively low bacterial counts compared
to their natural born counterparts (2007).

These findings are in agreement with previous

publications showing that differing modes of delivery result in altered bacterial communities [4951]. The work done by Palmer’s group focused on a long-term investigation, analyzing fecal
content up to one-year post delivery. They showed that anaerobic bacteria start to take over
colonization up through the first year of life, and that at this point the microbiota is strikingly
different than earlier months of development, and more similar in structure to the general adult
microbiota. As was previously stated these studies have illustrated the difference in infant
microbiota shortly after birth and later on during infancy. It appears that the “creation” of this
adult-like community is associated with an infant’s consumption of solid foods [48]. Lastly,
while it is documented that delivery method, infant feeding type (breast versus formula), and
antibiotic use during infancy affect the microbial structure; it is agreed that young children
possess an intestinal microbiota similar to that of adults consisting mainly of anaerobic groups
(Clostridia, Eubacterium, Proteobacteria, etc.) [48-52].

Aging and Microbiota Structure
The adult microbiota is another topic of interest among researchers. In comparison
studies between elderly (>=60yr) and adult (20-50yr) sample groups, there appears to be differing
9

opinions that Bacteroides/Prevotella species decrease in the elderly population, along with
similar decreases in Bifidobacteria species as well, while other studies report opposite findings.
It is possible that these contradictions are due to differing experimental methods (use of
fluorescent in situ hybridization, sequencing, classical microbiological techniques, etc.), as well
as variation associated with geography, diet, and subjects themselves. [17, 53-57] For instance
Claesson et al., report an increase in Bacteroides, along with an observed increase in
Faecalibacterium in elderly subjects compared to younger subjects (20-25% and 5-8% compared
to 5-8% and 4-7% respectively). In comparison, Enk et al. reported differing results claiming a
decrease in Bacteroides numbers; however this study was done using classical techniques that
under represent obligate anaerobes and organisms that remain difficult to extract and cultivate.
While variation does exist between subjects at a genus level, there is evidence to support the
notion that at higher taxonomic levels there exist more stability [53, 57]. The majority of
previous reports stop analysis at higher phylogenies, which might be explained by observed
variation at lower phyolenetic levels or the inability of the techniques utilized to assess these
lower levels.

External Factors Influencing Intestinal Microbiota Composition
While the intestinal microbiota has been shown to be stable long term [58], it is widely
accepted that this community can be influenced to some degree by host genotype, diet, and
immediate environment.

These studies document the influence of diet, host genome, and

surrounding environment on the intestinal microbiota.

Recently, studies assessing the microbiota related to the human genome have focused on
possible differences in twins, both with respect to inflammatory bowel disease and obesity [5962]. These studies found that monozygotic and dizygotic twin pairs shared a microbiome as well
10

as representative metabolic pathways that were in most cases significantly more similar to each
other than unrelated individuals [59-61]. Turnbaugh et al. even went so far as to show that these
twins shared greater similarity in their microbiota to their mother than to unrelated individuals
(2009). Although results from inflammatory bowel disease reports do not claim any significant
effect of the host genotype to susceptibility to intestinal disease, there remains a consensus that
host genotype relates to microbiota [59-62]. Zoetendal et al., in 2001, examined the intestinal
microbiota of

monozygotic twins, marital partners, unrelated individuals, and non-human

primates using denaturing-gradient gel electrophoresis, and noted a positive correlation between
shared genetic makeup and microbiota. The authors observed twins had the highest degree of
similarity in their microbiota composition, and with the exception of a few high similarity
observations, marital partners and unrelated individuals showed no significant difference in
degrees of similarity and were significantly lower than twins [63]. The results of all of these
studies suggest that host genotype plays an important role in microbiota makeup; however, the
degree of such affect has yet to be determined.

Another subject of interest is the relationship between diet and intestinal microbiota.
This subject is an area that has been widely studied, and although there has been no conclusive
argument that the intestinal microbiota is an effect of a causative diet, there is ample evidence to
suggest this [9-12, 14, 16-19, 64]. Most of the available literature examines this relationship by
analyzing the microbiota its relationship to extraction of nutrients from the host diet. This
approach has led to the concept that the microbiota is an environmental factor; contributing to
increased energy harvest from dietary contents [14, 16]. This is further documented by studies
assessing the effects of transplanting the intestinal microbiota of obese mice into lean recipients
and assessing dietary harvest.

Turnbaugh et al. showed that the transplantation of obese

microbiota into lean recipients resulted in an increase in Firmicutes while transplantation of lean
11

microbiota had no such effect [14]. These observations are in agreement with those of Backhed
et al. who determined that conventionally raised mice (harboring natural microbiota) had an
increased body mass when compared to germ free counterparts, despite consuming less chow
[41].

Backhed et al. illustrated a similar effect of transplantation of the microbiota from

conventionally raised mice to germ free counterparts. The germ free mice were colonized for 14
days with “unfractionated microbiota” leading to an increase in body fat content of fifty-seven
percent, even with a decrease in chow consumption [41].

The fecal content in the distal colon is not uniform [38], and exists as both liquid and
particle phases. Recent evidence has shown that each phase of the fecal matter harbors distinct
communities [38].

Particle phase fecal matter showed increased Firmicutes with lower

Bacteroidetes while liquid phase fecal matter was associated with a higher percentage of
Bacteroidetes and lower Firmicutes with respect to control [38]. This was suggested to be the
result of a resistancedfx. of certain carbohydrates in the diet, requiring action from multiple
bacterial species for breakdown and utilization.

Interestingly, studies performed on subjects consuming vegetarian diets showed increased
Bacteroides and distinct phylotypes (species) associated with such diet versus an omnivorous diet
including meat [10, 11]. Hehemann et al. 2010 explained the acquisition of a porphyrinase gene
common to marine Bacteroidetes, observed in the intestinal Bacteroidetes of Japanese subjects.
The authors proposed that this gene was acquired by the intestinal microbiota as a result of
repeated consumption of nori seaweed and the need to metabolize the plant wrap common with
this type of sushi preparation. The overall suggestion of this evidence is that the microbiota can
be altered after prolonged exposure to certain diets [11, 17, 64, 65].

12

Detection of Bacteria in the Intestinal Tract
Classical techniques for investigating intestinal microbiota in fecal content involve the
culturing and counting of isolated organisms. As a result, the initial assessment of the intestinal
microbiota suggested dominance by species such as Bacteroides, however; these results are
incomplete and lack accurate representation of fastidious and strict anaerobes [66, 67]. Tissue
and mucosal biopsies, and sampling of the lumen through colonic lavage and fecal collection
allow researchers to gain insight into the intestinal environment [68-72]. Advances in technology
have allowed researchers to bypass the need for cultivating bacterial cells, which is estimated to
only encompass thirty percent of the total microbiota population, and have created more robust
techniques [73].

One avenue that allows investigators to accurately identify the intestinal microbiota is
through looking at ribosomes. All living organisms contain ribosomes, as they are essential for
protein synthesis, and thus organisms can be related based on sequence similarity of ribosomal
subunits, specifically the small 16S subunit of prokaryotic ribosomes. This 1.5kb region of the
bacterial genome is very useful when it comes to determining diversity of the intestinal
microbiota as it contains both conserved regions as well as species-specific variable regions. In
addition to this, two of the conserved regions on the 16S ribosomal DNA happen to lie near the
ends of the sequence, therefore researchers are accurately able to amplify the entire 16S sequence
and then do more specific interrogation into specific variable regions for bacteria of interest [7478].

13

New techniques including denaturant-gradient gel electrophoresis, 16S high-throughput
sequencing, are able to determine presence of dominant species as well as detect novel species,
yet lack the quantitative ability of quantitative-PCR, dot-blot hybridization, and fluorescent insitu hybridization. The limitations of these latter technologies include the difficulty of applying
them to large populations [74]. The outcome of studies using such advanced technology have
provided a modern image of the intestinal microbiota, showing a predicted greater presence of
obligate anaerobes, permitting metabolomic studies and investigations into the relationship of
these newly detected organisms to human health and disease [11, 17, 64, 69, 70, 75, 77, 78].

The development of microarray technology has been extremely beneficial in the pursuit
of establishing a complete picture of the intestinal microbiota. Microarrays are capable of
detecting thousands of species and, encompassing large populations; they have also been shown
to be accurate and reliable [74, 75, 79]. Currently, there are a few different microarray platforms,
one of the more well known is the Human Intestinal Tract chip (HITchip), which was recently
applied to young and elderly adults and shown to be more reliable than DGGE fingerprinting,
further solidifying the microarray as a superior technique [79]. Recently Paliy et al. designed a
custom Microbiota Array to be used in the analysis of human fecal content. The Microbiota
Array was shown to detect accurately fifteen bacterial species tested; both when hybridized
individually to the array and in mixed communities. The authors also showed the ability of the
Microbiota Array to distinguish and accurately detect bacterial species when human DNA was
mixed with mixed bacterial samples. They also demonstrate the sensitivity of the Microbiota
Array by running 16S specific PCR up to thirty-cycles which permitted the detection limit of the
Microbiota Array to drop from 4ng of bacterial genomic DNA to merely 10pg [75]. The Paliy lab
also recently published a report addressing the optimization of the microarray process. One
aspect of this report was the adjustments for both potential cross-hybridization and 16S gene copy
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numbers possessed by different bacteria [80]. The outcome of such adjustments resulted in
decreased abundance of highly abundant bacteria and increased abundance of lower abundant
bacteria. This suggests that previous reports may have inadvertently over- or under represented
certain bacterial groups. Overall, the development and validation of microarrays has enabled
researchers to get a significantly better quantitative understanding of microbiota populations.

Thesis Overview
The following work describes the use of a Microbiota Array to accurately assess and
determine the structure of the intestinal microbiota. Fecal samples were obtained from healthy
adult volunteers. Bacterial genomic DNA was extracted and subjected to 16S PCR, followed by
DNA fragmentation, end labeling with biotin, and hybridization onto the microarray.
Microarrays were washed and stained according to Affymetrix protocol and scanned to measure
fluorescence intensity, determining presences/absence calls and signal values. Presence and
absence calls, along with probeset signal values were imported into a MICROSOFT EXCEL
template created by Dr. Oleg Paliy; this template aided in determination of intestinal microbiota
numbers. The results of this work provide quantitative information into the makeup of the human
distal-gut microbiota, are a useful complement to other microarray studies, and can be combined
with metabolomic, co-morbidity, proteomics, and other such investigations to continue and
understand the significance of the intestinal microbiota in human health and disease.
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2. Materials and Methods
Sample Collection
Fecal samples were obtained from 10 healthy adult volunteers with ages ranging from 2261 yrs. Volunteers were asked to defecate into sterile sample collection containers; samples were
frozen immediately after collection at -80°C. Aliquots of frozen stool material were taken for
processing and microarray interrogation (samples were kept on dry ice to increase thawing time
and keep DNA integrity intact). Table 2.1 indicates age and gender of each volunteer, except
when information was not given (N/G).
Table 2.1Volunteer Age and Gender Assignment
Sample
aHLT01
aHLT02
aHLT03
aHLT04
aHLT05
aHLT06
aHLT07
aHLT08
aHLT09
aHLT10

Age
25
22
35
61
36
44
23
N/G
N/G
28

Gender
F
F
M
M
M
F
M
N/G
N/G
F

DNA Extraction
Total genomic DNA (gDNA) was extracted with the ZR Fecal DNA Kit (Zymo Research
Corp), using the supplied directions:
a) 150 mg of fecal matter was added to a ZR Bashing Bead Lysis Tube followed by 750 μL
of lysis buffer.
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b) ZR Bashing Bead Lysis Tube was placed in a Disruptor Genie® and processed for 5
minutes.
c) Tube was centrifuged at approx. 10,000 g for 1 minute, followed by a transfer of 400 μL
of supernatant to a Zymo-Spin IV Spin Filter (inside collection tube) and centrifuged at
7,000 g for 1 minute.
d) 1,200 μL of Fecal DNA Binding Buffer was added to the filtrate and 800 μL of this
mixture was transferred to a Zymo-Spin IIC Column (inside collection tube) and
centrifuged at 10,000 g for 1 minute.
e) Flow-through was discarded and the previous step repeated; due to a 800 μL limit in the
Zymo-Spin IIC Column this process must be repeated multiple times.
f) 200 μL of Fecal DNA Pre-Wash Buffer was added to the Zymo-Spin IIC Column and
centrifuged at 10,000 g for 1 minute.
g) 500 μL of Fecal DNA Wash Buffer was added to the Zymo-Spin IIC Column and
centrifuged again at 10,000 g for 1 minute.
h) Total genomic DNA was eluted with 100 μL of water, after transferring the Zymo-Spin
IIC Column to a clean micro-tube and adding water directly to column matrix; the microtube was then centrifuged at 10,000 g for 30 seconds.
i)

Eluted DNA was passed through the Zymo-Spin IV-HRC Spin Filter, placed in a clean
micro-tube; and spun down at 8,000 g for 1 minute.

Once gDNA was eluted, yield and quality (determined by A260/A280 ratio) were assessed by
Nanodrop 1000. Extracted gDNA was used as starting material for all replicates of downstream
processing.
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Bacterial 16S rDNA amplification and purification
Total gDNA, which contains eukaryotic, prokaryotic, and viral DNA was subjected to
selective amplification of the 16S rRNA gene through 16S rDNA-specific PCR amplification.
Amp_27F-(AGRGTTYGATYMTGGCTCAG) and Amp_1492R-(GYTACCTTGTTACGACTT)
primers, designed to conserved regions of the 16S ribosomal DNA sequence [75], were used to
specifically amplify the bacterial 16S rRNA gene. The PCR reaction was carried out in a 50 μL
volume with 1 μL (10 pmoles) of each primer, 25 μL of Taq 2X Master Mix (New England
Biolabs) which incorporates 0.2mM of each dNTP (deoxy-nucleotide triphosphate) and 25U/ml
of the Taq DNA polymerase, 250 ng of total gDNA starting template (percentage 16S-0.0025%
of genome), and water. Each sample was subjected to 4 PCR reactions, carried out in the MJ
Thermocycler. Each reaction consisted of 25 cycles of amplification; each cycle was run at 95°C
for 30 s - 55°C for 30 s - 72°C for 90 s. To decrease PCR bias, all 4 reactions were pooled
together.
Table 2.2 PCR Reaction Mix
PCR
Reaction
H2O
27F_V4
1492_R
gDNA
Taq 2X
Total

Amount
up to 50 μL
1 μL
1 μL
250 ng
25 μL
50 μL

The amplified DNA product was subjected to purification using the Qiaquick PCR
Purification kit (Qiagen) based on the following protocol:
a) Five volumes of PB Buffer was added to one volume of the PCR reaction, transferred to a
PCR purification column and centrifuged at 17,900 g for 1 minute.
b) The flow-through was discarded and 750 μL of Buffer PE added to the column, placed
back in the collection tube, and centrifuged for 1 minute at 17,900 g.
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c) Flow-through was discarded, and the column spun down again to ensure removal of
buffer.
d) The spin column was transferred to a new collection tube and 30 μL of RNase free water,
heated to 50C, was added to the center of the column and let to sit for 2 minutes (the
supplied protocol instructed using room temperature water and sitting for 1 minute, this
led to poor yield, therefore the protocol was changed with the addition of warmer water
and a longer sit time).
e) The column was centrifuged at 13,000 g for 1 minute to elute PCR amplified DNA.
The 16S amplification and purification was verified on a 1% agarose gel run at 75 V for 1
hour. 1 μL of amplified DNA was combined with 2 μL gel loading dye (6X) and 9 μL water,
then loaded onto the gel. Positive verification of correct 16S amplification was seen with a single
band at approximately 1.5kb when compared with a 2-log Ladder (NEB).

16S Fragmentation
In order to interrogate the 16S rDNA with the microarray, the amplified 16S rDNA was
fragmented using Dnase I (NEB) and verified on a 10% poly-acrylamide gel. The fragmentation
reaction consisted of 1800 ng of 16S rDNA amplified pool, 4 μL Dnase buffer, Dnase I (0.04
U/μg), and water to a final volume of 40 μL. The reaction was run in a MJ Thermocycler at 37°C
for 10 min followed by 98°C for 10 min to deactivate the enzyme. 300 ng of fragmented 16S
rDNA was removed from each reaction mix and combined with gel loading dye and water to a
final volume of 6 μL, which was then added to the gel and run at 75 V for 90 minutes. A 50 bp
dsDNA ladder was used to determine whether DNA fragments were within the desire 100-300 bp
size.

19

Figure 2.1 Fragmentation PAGE Gel

Microbiota Array
The Microbiota Array is a custom designed phylogenetic array, based off the Affymetrix
GeneChip design. Microbiota Array contains probes to 775 phylo-species inhabiting the distal
gut. Probes contain 25 nucleotides and are grouped in probesets, ranging from 5-11 probes per
set (84% of probesets contain 11 probes). Probe sets incorporate Perfect Match and Mismatch
probes.

DNA Labeling and Hybridization
Fragmented DNA was end-labeled with biotin and then loaded onto the Microbiota
Array. The labeling reaction combined Terminal Deoxynucleotidyl Transferase (TdT), along
with buffer; Gene Label Reagent, fragmented DNA, and CoCl2. This reaction mix was incubated
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in the MJ-Thermocycler at 37°C for 1 hour and then stopped by the addition of 2 μL of 0.5M
EDTA.
Table 2.3 Labeling Reaction Mix
Labeling Reaction
10x TDT Buffer
CoCl
TDT (Transferase)
Fragmented DNA
Gene Label Reagent
H2O
Total Volume

Amount
5 μL
5 μL
2 μL
1500 ng
2 μL
up to 50 μL
50 μL

After labeling was completed, the DNA cocktail was ready to be added to the microarray for
hybridization.

Affymetrix protocol combines fragmented/labeled DNA, hybridization buffer

(2X), Control oligo B2, DMSO, Herring sperm DNA (10mg/ μL), and BSA (50mg/ μL).
Table 2.4 Hybridization Reaction Mix
Hybridization Mix
Frag.;Labeled cDNA
2X Hybridisation Buffer
Control Oligo B2
100% DMSO
10 mg/ml Herring Sperm
DNA
50 mg/ml BSA
Total Volume

Amount
1500 ng
up to 65 μL
2.2 μL
10.2 μL
1.3 μL
1.3 μL
130 μL

Once the hybridization cocktail components were combined, the mixture was added to the
microarray and then placed into the hybridization oven for 16 hours at 45°C and 60 rpms.

Washing, Staining, and Scanning of Microarray
Upon completion of hybridization the microarray was removed from the oven, then
washed and stained in an Affymetrix Fluidics 450 station. Stains, along with Non-Stringent
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Wash Buffer A and Stringent Wash Buffer B were prepared in accordance with Affymetrix
recipes.

The microarray was removed from the hybridization oven after 16 hours; the

hybridization mix was removed and frozen at -20°C, replaced with 160 μL of Non-Stringent
Wash Buffer A, and loaded into the Fluidics 450 along with stains. Once loaded, the array was
washed and stained using the “Midi-euk_2v3_450” protocol. Upon completion of staining, the
microarray was transferred to the Affymetrix GeneChip Scanner where it was scanned,
fluorescence measured and recorded.
Table 2.5 Stains for Microarray
Streptavidin Vial 1
2x Stain Buffer
50 mg/ml BSA
1 mg/ml Streptavidin
H2O
Total Volume

Amount
300 μL
24 μL
6 μL
270 μL
600 μL

Antibody Soln. Vial 2
2x MES Stain Buffer
50 mg/ml BSA
10 mg/ml Goat IgG
0.5 mg/ml Anti-strep
H2O
Total Volume

Amount
300 μL
24 μL
6 μL
6 μL
264 μL
600 μL

SAPE Soln. Vial 3
2x MES Stain Buffer
50 mg/ml BSA
1 mg/ml SAPE
H2O
Total Volume

Amount
300 μL
24 μL
6 μL
270 μL
600 μL

Normalization and Analysis of Microarray Data
Microarray

data

were

normalized

using

the

CARMAweb

server

(https://carmaweb.genome.tugraz.at/carma) [81]. Normalization of the data was carried out using
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Mas5 algorithm for background correction, VSN for normalization, Mas5 for PM correction, and
Median Polish for expression.

After the normalization was completed, these values, along with presence and absence
calls (calculated by GCOS software) were inserted into a MICROSOFT EXCEL template
provided by Dr. Paliy; this template allowed for calculation of abundances for bacterial groups at
multiple phylogenetic levels. Microarray replicates showed good concordance with one another,
as viewed through correlation of probe signal values between replicates (0.89-0.94, ave. 0.92).

To assess core microbiome, presence and absence calls were converted to binary (1/0)
form and loaded into Matlab. It was here that data was subjected to rarefaction, which determines
how well populations are sampled and can be used to determine how many species are shared
between samples.

This is accomplished by doing comparisons of all possible sample

combinations and assessing what is shared among all samples over each comparison.

Phylogenetic Tree Construction
Phylogenetic tree was created using BOSQUE [82].

Sequences of the 775 phylo-

species on Microbiota Array were imported into BOSQUE and aligned using MUSCLE
algorithm. Following alignment, Phylip method was applied for tree construction.
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3. RESULTS
Intestinal Microbiota at the Phylum Level
This study was carried out to determine the intestinal composition of the microbiota of
healthy adult individuals through the use of a custom designed Microbiota Array. Fecal samples
were collected from 10 healthy adult volunteers. Adults ranged in age from 22 to 61 years of age,
had not taken antibiotics within 3 months prior to donating samples, and were all in general good
health. Samples were frozen upon collection to maintain DNA integrity.

Bacterial genomic DNA was extracted from fecal matter and subsequently processed for
interrogation by a previously designed Microbiota Array. After washing and staining, the array
was scanned, the output signals were normalized in CARMAweb and then imported into an
EXCEL template to aid in analysis of microarray data.

Adjusted microarray results showed that the intestinal microbiota is dominated
by the phyla Firmicutes, Actinobacteria, Bacteroidetes, and Proteobacteria at 80%, 7%, 9% and
3% abundance, respectively (Table 3.1). Seven out of ten phyla were present to some extent
(Table 3.2). As average relative abundance decreased it was observed that variation among
samples increased. This observed pattern in the variation of phyla among samples suggests that
bacteria which are essential for proper gut health are present at similar levels in all people,
whereas those bacteria which vary significantly can be thought of as disposable. Overall, certain
phyla were more different in abundance across samples. This varying abundance pattern suggests
that those phyla with higher variation are not as important with respect to intestinal homeostasis.
An example of this, seen in Table 3.2, is Actinobacteria with abundances ranging from 0.9% to
15.9%.
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St. Deviation

Coefficient of Variation

Proteobacteria

2.7%

2.25%

83.8%

Firmicutes

79.8%

7.38%

9.2%

Actinobacteria

7.2%

5.41%

75.2%

Spirochaetes

0.1%

0.08%

108.3%

Bacteroidetes

8.8%

2.97%

33.7%

Verrucomicrobia

1.0%

0.83%

84.6%

Lentisphaerae

0.4%

0.93%

251.2%

Phylum

Average Abundance

TABLE 3.1 Overview of Phylum Level Abundances

Table 1 shows the average relative abundance of intestinal bacterial phyla among ten healthy
adult volunteers, along with standard deviation. There is a pattern of increasing standard
deviation with respect to the abundance of each phylum. Coefficient of variation was calculated
to determine the extent of variation among samples.

aHLT01

aHLT02

aHLT03

aHLT04

aHLT05

aHLT06

aHLT07

aHLT08

aHLT09

aHLT10

TABLE 3.2 Abundances of Phyla among Individual Samples

Proteobacteria

1.9%

4.7%

0.4%

0.5%

5.2%

3.6%

0.4%

6.7%

1.2%

2.2%

Firmicutes

82.9%

65.6%

90.4%

86.8%

78.5%

72.3%

84.8%

75.7%

77.7%

83.3%

Actinobacteria

4.3%

14.9%

1.1%

0.9%

1.9%

15.9%

9.8%

5.7%

9.5%

8.1%

Spirochaetes

0.3%

0.1%

0.0%

0.0%

0.1%

0.0%

0.1%

0.1%

0.1%

0.0%

Bacteroidetes

7.8%

12.7%

7.3%

10.5%

13.4%

5.8%

4.7%

8.8%

11.0%

6.2%

Verrucomicrobia

2.8%

1.5%

0.7%

1.2%

1.0%

1.6%

0.3%

0.0%

0.5%

0.2%

Lentisphaerae

0.0%

0.6%

0.0%

0.0%

0.0%

0.1%

0.0%

3.0%

0.0%

0.0%

Phylum

Table 2 illustrates relative abundances of seven phyla of human intestinal microbiota. Firmicutes
was most abundant, followed by Bacteroidetes. Certain phyla showed more variation among
samples than other, which suggests varied levels of importance among observed phyla. One case
is Actinobacteria which had a large range of abundance (min-0.9%, max-15.9%).
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Class Level Microbiota Structure
Class level results illustrated that Clostridia, a dominant member of the Firmicutes
phylum, was most abundant at 74.0% with Bacteroidetes following at 8.8% (Table 3.3).
Actinobacteria and Bacilli were the next most abundant classes at 7.2% and 3.7% respectively;
however the ratio of standard deviation-to-abundance suggests that the variability among each
sample is high and thus might point out potential outliers.

Figure 3.1 shows microbiota

encompassing 10 adult samples. Species that were present in at least 1 of the samples were
included in the tree. The tree was created using the Bosque software [82], employing the Phylip
(F84) distance method for construction. While most of the species contained in the tree belong
to Clostridia, and the distribution of groups within the tree matches the numerical abundance
data; there were some species that grouped closely together, despite being from different classes
according to our classification (indicated by asterisk). The RDP IDs were taken and put into
RDPs browser function, and came back as “unclassified_Firmicutes” indicating that recent
updates to the RDP database have altered the classification of these entries.

Average
Abundance

St.
Deviation

Coefficient
of Variation

Table 3.3 Average Abundance of Classes Comprising the Intestinal Microbiota

0.2%

0.8%

316.2%

1.4%

1.4%

102.1%

0.4%

0.4%

108.0%

0.7%

0.7%

95.0%

Proteobacteria

<0.1%

<0.1%

255.4%

Clostridia

Firmicutes

74.0%

5.6%

7.6%

Mollicutes

Firmicutes

2.0%

2.4%

118.8%

3.7%

2.3%

61.4%

7.2%

5.4%

75.2%
108.3%

Class

Corresponding
Phylum

Alphaproteobacteria

Proteobacteria

Betaproteobacteria

Proteobacteria

Gammaproteobacteria

Proteobacteria

Deltaproteobacteria

Proteobacteria

Epsilonproteobacteria

Bacilli

Firmicutes

Actinobacteria

Actinobacteria

Spirochaetes

Spirochaetes

0.1%

0.1%

Bacteroidetes

Bacteroidetes

8.8%

3.0%

33.7%

Verrucomicrobiae

Verrucomicrobia

1.0%

0.8%

84.6%

Lentisphaerae

Lentisphaerae

0.4%

0.9%

251.2%
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Table 3 depicts class level relative average abundance, standard deviation, and variation. As seen
with the phylum level, there exists an increase in standard deviation related to decreased
abundance. Clostridia was dominant at more than eight-times the abundance of any other class.
Variation again, increases as abundance decreases, this highlights classes which are present in
only a few samples overall; leading to such higher variation.
Figure 3.1 Class Makeup

Figure 3.1 is a Cladogram illustrating class-level makeup of intestinal microbiota. Polygon size
is relative to the number of phylo-species present, exceptions to this are classes where the number
of present phylo-species was less than the smallest default polygon size. Species that are not part
of a polygon are either the only representative of their class, or have recently been reclassified as
“unclassified_Firmicutes” (asterisk) or Eubacterium (yellow triangle).
Beyond the four most abundant classes, the standard deviation was seen to be almost as high as
the average observed abundance, if not higher. This pattern in the standard deviation, coupled
with the variation, suggested that specific samples harbored large abundances of bacteria
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compared to the same group in other samples. Upon looking at each individual sample, specific
differences accounted for the variation (Table 3.4, Figure 3.2), however Alphaproteobacteria and
Epsilonproteobacteria were represented in only one sample each (aHLT08 and aHLT09
respectively). This unique presence of these two classes is not enough to treat the samples as
uniquely different but may potentially suggest a sort of microbial “fingerprint” when combined
with other differences in the observed population structure.

For instance, the presence of

Alphaproteobacteria in aHLT08 at 2.4% compared to an absence in all other samples could be
indicative of diet or even age (note: age for this individual not given).

aHLT01

aHLT02

aHLT03

aHLT04

aHLT05

aHLT06

aHLT07

aHLT08

aHLT09

aHLT10

Table 3.4 Abundances of Classes of the Intestinal Microbiota across Healthy Adults

Alphaproteobacteria

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

2.4%

0.0%

0.0%

Betaproteobacteria

0.1%

2.7%

0.0%

0.5%

2.9%

2.7%

0.3%

3.5%

0.8%

0.2%

Gammaproteobacteria

0.0%

1.0%

0.3%

0.0%

1.0%

0.1%

0.1%

0.1%

0.4%

0.4%

Deltaproteobacteria

1.8%

0.9%

0.1%

0.0%

1.3%

0.8%

0.0%

0.8%

0.0%

1.6%

Epsilonproteobacteria

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

0.1%

0.0%

Clostridia

76.8%

62.7%

80.0%

79.2%

68.3%

70.0%

79.7%

72.7%

75.1%

75.8%

Mollicutes

1.7%

0.8%

6.0%

6.9%

2.3%

0.6%

0.4%

0.6%

0.4%

0.7%

Bacilli

4.4%

2.1%

4.4%

0.8%

7.9%

1.8%

4.7%

2.4%

2.2%

6.8%

Actinobacteria

4.3%

14.9%

1.1%

0.9%

1.9%

15.9%

9.8%

5.7%

9.5%

8.1%

Spirochaetes

0.3%

0.1%

0.0%

0.0%

0.1%

0.0%

0.1%

0.1%

0.1%

0.0%

Bacteroidetes

7.8%

12.7%

7.3%

10.5%

13.4%

5.8%

4.7%

8.8%

11.0%

6.2%

Verrucomicrobiae

2.8%

1.5%

0.7%

1.2%

1.0%

1.6%

0.3%

<0.1%

0.5%

0.2%

Lentisphaerae

0.0%

0.6%

0.0%

0.0%

0.0%

0.1%

0.0%

3.0%

0.0%

0.0%

Class

Table 3.4 represents individual abundances of Classes interrogated by the Microbiota Array. Of
particular note was Actinobacteria with a range of 15% across all samples, (lowest-0.9%, highest15.9%), interesting given the average for this class was approximately half the largest value.
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Figure 3.2 Distribution of Classes of Intestinal Microbiota in Healthy Adults

Figure 3.2 illustrates distribution of Classes across adult samples. Values were plotted on a log
base 10 scale and represent Class abundances over 10 healthy adults. Black bars indicate average
relative abundance for each class as shown in Table 3.
Overall, class level microbial structure is dominated by three classes, Clostridia, Bacteroidetes,
and Actinobacteria, which account for 90% of the intestinal microbiota. Abundance is based
upon presence of phylo-species; therefore, we assessed phylo-species detection for each class,
with the purpose of determining any relationship between abundance of classes and those phylospecies that were detected for each class. Table 3.5 shows the average counts of detected phylospecies in decreasing order of present phylo-species.
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Average #
Probesets

St. Deviation

Coefficient of
Variation

Table 3.5 Phylo-species Numbers of Classes of the Intestinal Microbiota

Alphaproteobacteria

Proteobacteria

0.1

0.3

316.2%

Betaproteobacteria

Proteobacteria

2.3

1.3

58.2%

Gammaproteobacteria

Proteobacteria

2.9

1.0

34.3%

Deltaproteobacteria

Proteobacteria

1.0

0.9

94.3%

Epsilonproteobacteria

Proteobacteria

0.2

0.4

210.8%

Clostridia

Firmicutes

266.3

20.0

7.5%

Mollicutes

Firmicutes

4.8

1.7

35.1%

Bacilli

Firmicutes

9.7

2.5

25.3%

Actinobacteria

Actinobacteria

10.9

4.5

41.4%

Spirochaetes

Spirochaetes

0.7

0.5

69.0%

Bacteroidetes

Bacteroidetes

29.6

10.6

35.8%

Verrucomicrobiae

Verrucomicrobia

0.9

0.3

35.1%

Lentisphaerae

Lentisphaerae

0.4

0.5

129.1%

Class

Corresponding
Phylum

Table 3.5 indicates average number of probesets detected. This is relative to the number of
phylo-species for each class.
The difference in pattern of detected phylo-species within each class compared to the
decreasing abundance as seen in Table 3.3 suggests a potential for alternate assessment of
microbiota as it relates to diet. In contrast with class level abundance the decreasing order of the
number of detected phylo-species differed, mainly among proteobacteria members (Table 3.2
versus Table 3.3). The difference between detected phylo-species and abundance level among
each class may suggest differences in the importance of certain phylogenetic groups. In other
words, different people may harbor similar groups of bacteria, but subtle life differences could
lead to different sizes of each bacterial group. This may also be explained by determining the
present-phylo species per sample, as is shown in Figure 3.3 Variation among detected probesets
was, at most, in agreement with variation in abundance values, in many cases the variation
between probesets was much less (Table 3.2 versus Table 3.3).
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Figure 3.3 Numbers of Phylo-species within Classes

Figure 3.3 shows detected probesets for each Class across individuals. Values are plotted on a
log base 2 scale.

Families of the Intestinal Microbiota
While previous studies have dealt with class level microbiota structure, this does not give
sufficient evidence of specificity in the intestinal microbial community. The Microbiota Array
allowed us to take a look into family groups. Results showed that out of forty-seven possible
familial groups interrogated, twenty-seven were detected in at least one sample, with the
remaining twenty not being detected at all (Table 3.6). Of those families that were found present,
Lachnospiraceae, Clostridiaceae, and Acidaminococcaceae made up roughly 69% of total signal
(36%, 24%, and 8% respectively); of note since these three families all belong to the class
Clostridia. Durban et al. ([83]) report similar results with Ruminococcaceae as most abundant in
fecal samples, followed by Lachnospiraceae and Bacteroidaceae.
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Average
Abundance

Standard
Deviation

Coefficient of
Variation

Table 3.6 Average Relative Abundances of Family Groups

Rhodobacteraceae

Alphaproteobacteria

-

-

-

Sphingomonadaceae

Alphaproteobacteria

-

-

-

Phyllobacteriaceae

Alphaproteobacteria

-

-

-

Bradyrhizobiaceae

Alphaproteobacteria

-

-

-

Methylobacteriaceae

Alphaproteobacteria

-

-

-

Methylocystaceae

Alphaproteobacteria

-

-

-

Rhodobiaceae

Alphaproteobacteria

0.2%

0.8%

315.4%

Burkholderiaceae

Betaproteobacteria

0.2%

0.2%

109.2%

Oxalobacteraceae

Betaproteobacteria

-

0.1%

301.0%

Alcaligenaceae

Betaproteobacteria

1.1%

1.4%

125.6%

Neisseriaceae

Betaproteobacteria

-

-

-

Xanthomonadaceae

Gammaproteobacteria

-

-

-

Moraxellaceae

Gammaproteobacteria

-

-

-

Succinivibrionaceae

Gammaproteobacteria

-

-

-

Enterobacteriaceae

Gammaproteobacteria

0.1%

0.2%

163.9%

Pasteurellaceae

Gammaproteobacteria

0.2%

0.3%

142.1%

Desulfovibrionaceae

Deltaproteobacteria

0.7%

0.7%

95.3%

Campylobacteraceae

Epsilonproteobacteria

-

0.0%

220.2%

Helicobacteraceae

Epsilonproteobacteria

-

-

-

Clostridiaceae

Clostridia

24.2%

2.3%

9.4%

Lachnospiraceae

Clostridia

36.1%

4.3%

Peptostreptococcaceae

Clostridia

-

-

11.8%
-

Eubacteriaceae

Clostridia

4.9%

1.0%

20.2%

Peptococcaceae

Clostridia

0.6%

0.8%

130.8%

Acidaminococcaceae

Clostridia

8.2%

1.9%

22.9%

Thermoanaerobacteriaceae

Clostridia

0.1%

0.1%

136.7%

Erysipelotrichaceae

Mollicutes

2.0%

2.4%

Staphylococcaceae

Bacilli

-

-

118.8%
-

Turicibacteraceae

Bacilli

0.2%

0.2%

113.7%

Lactobacillaceae

Bacilli

0.1%

0.2%

268.6%

Enterococcaceae

Bacilli

0.1%

0.2%

213.4%

Streptococcaceae

Bacilli

2.8%

1.8%

66.4%

Firmicutes - IS9

Bacilli

0.6%

0.7%

111.2%

Coriobacteriaceae

Actinobacteria

1.6%

0.7%

43.9%

Actinomycetaceae

Actinobacteria

-

0.0%

91.7%

Family

Corresponding Class
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Micrococcaceae

Actinobacteria

-

-

-

Dermabacteraceae

Actinobacteria

-

-

-

Corynebacteriaceae

Actinobacteria

-

-

-

Bifidobacteriaceae

Actinobacteria

5.5%

4.8%

87.0%

Serpulinaceae

Spirochaetes

0.1%

0.1%

106.7%

Leptospiraceae

Spirochaetes

-

-

-

Bacteroidaceae

Bacteroidetes

5.9%

1.9%

32.0%

Rikenellaceae

Bacteroidetes

1.5%

0.9%

59.7%

Porphyromonadaceae

Bacteroidetes

0.4%

0.7%

168.0%

Prevotellaceae

Bacteroidetes

1.1%

2.0%

184.0%

Verrucomicrobiaceae

Verrucomicrobiae

1.0%

0.8%

84.1%

Victivallaceae

Lentisphaerae

0.4%

0.9%

250.6%

Table 6 depicts families interrogated by the Microbiota Array.
represented with “-“.

Groups not detected are

The difference between Durban et al.’s findings and those here could be due to differing
techniques (they applied cloning and sequencing), classification version (results here are based
off of RDP version 4, although RDP database is updated frequently) or study design, as Durban’s
group did not appear to exclude subjects recently on antibiotics or who had a BMI that would
indicate the subject was overweight.

Of those families present it is interesting to note that

multiple members of the class Clostridia are present at higher abundances, while only one
member of Bacteroidetes and Actinobacteria are present.

This pattern of abundance suggests

that while some larger taxa may represent greater proportions, they may not be an essential factor
in maintaining homeostasis in the intestinal tract. This shows that analysis of lower taxonomical
levels will reveal more detail and allow for a better understanding of the intestinal microbiota.

Microbiota Constituents - Genus Contribution
The Microbiota Array interrogates for 115 bacterial genera, 22 of which had abundances
equal or greater to 1%.

The major contributors were Ruminococcus at 21%, followed by

Faecalibacterium at 9% (Table 3.7). This large difference between Ruminococcus and the other
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present genera is of particular note as it gives evidence of this particular genus’ role in
metabolism, as a primary degrader.

Corresponding
Class

Average
Abundance

St. Deviation

Coefficient of
Variation

Table 3.7 Average Relative Abundance of Intestinal Genera

Sutterella

Betaproteobacteria

1.1%

1.4%

125.5%

Clostridium

Clostridia

1.9%

0.9%

47.0%

Acetivibrio

Clostridia

2.7%

1.2%

44.9%

Anaerotruncus

Clostridia

3.2%

1.5%

47.3%

Dorea

Clostridia

2.2%

0.8%

35.7%

Faecalibacterium

Clostridia

8.7%

2.3%

26.6%

Subdoligranulum

Clostridia

2.5%

0.8%

33.6%

Lachnospira

Clostridia

4.2%

1.2%

29.5%

Anaerostipes

Clostridia

2.1%

0.4%

18.6%

Coprococcus

Clostridia

1.8%

1.2%

68.0%

Roseburia

Clostridia

6.1%

1.5%

24.2%

Ruminococcus

Clostridia

21.1%

2.8%

13.3%

Eubacterium

Clostridia

4.2%

0.9%

22.6%

Papillibacter

Clostridia

6.8%

1.8%

26.5%

Holdemania

Mollicutes

1.8%

2.3%

130.8%

Streptococcus

Bacilli

2.3%

1.4%

62.2%

Collinsella

Actinobacteria

1.1%

0.7%

65.8%

Bifidobacterium

Actinobacteria

5.5%

4.8%

86.9%

Bacteroides

Bacteroidetes

5.5%

1.6%

29.7%

Alistipes

Bacteroidetes

1.4%

0.9%

62.5%

Prevotella

Bacteroidetes

1.1%

2.0%

184.1%

Verrucomicrobium

Verrucomicrobiae

1.0%

0.8%

84.6%

Genus

Table 3.7 shows genera present at 1.0% or more. Standard Deviation and Coefficient of
Variation were calculated to illustrate commonality of each genus among samples, as well as
highlight potential differences which may give weight to the presence of specific genera.
The order of presence is of note for another reason, being that while there has been work
done with Ruminococcus, Faecalibacterium, Bifidobacterium, and Roseburia with respect to
nutrient requirements, there still remains some gaps in the knowledge surrounding the intricacies
of Papillibacter. While work has been performed on lower-level taxonomical groups, much of
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these studies have been focused on higher groups, possibly due to the stability seen with higher
taxonomies. The fact that Papillibacter is among the more abundant members in the intestinal
environment, suggests that its role in aiding and coordinating metabolic function in the intestine
warrants future study.
Figure 3.4 Variation of Intestinal Genera Among Healthy Adults

Figure 3.4 shows relative abundances and of genera for each sample along with average relative
abundance of each genus.
Because microorganisms are essential for proper intestinal health, it becomes a curious
issue to address individual uniqueness at these lower taxonomical levels. Faecalibacterium,
Papillibacter, and Roseburia all had similar variation as calculated through coefficient of
variation (26%, 26%, and 24% respectively), and abundances between samples show that there
are few outliers (defined by samples with abundance values two or more standard deviations from
the mean) (Table 3.8). This illustrates that these genera belong to a functionally important group
with respect to intestinal homeostasis. Figure 3.4 shows how extensive the variation was for each
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of the top 22 genera. From this image it can be inferred that some genera, carrying less variation
across samples, possess necessary (and potentially unknown) functions. The variation observed
in Faecalibacterium may be an indicator of patient diet as this organism is known to be
associated with dietary fiber and particle-phase fecal content [38].

aHLT03

aHLT04

aHLT05

aHLT06

aHLT07

aHLT08

aHLT09

aHLT10

Sutterella
Clostridium
Acetivibrio
Anaerotruncus
Dorea
Faecalibacterium
Subdoligranulum
Lachnospira
Anaerostipes
Coprococcus
Roseburia
Ruminococcus
Eubacterium
Papillibacter
Holdemania
Streptococcus
Collinsella
Bifidobacterium
Bacteroides
Alistipes
Prevotella
Verrucomicrobium

aHLT02

Genus

aHLT01

Table 3.8 Relative Abundance of Intestinal Genera Across Adult Samples

0.0%
1.1%
1.7%
4.8%
2.0%
9.0%
1.7%
4.3%
1.6%
1.2%
7.7%
22.8%
4.1%
7.2%
1.5%
3.9%
0.0%
3.4%
5.7%
2.2%
0.0%

2.7%
3.0%
1.6%
2.5%
2.4%
8.9%
0.7%
2.8%
1.9%
0.0%
3.6%
18.8%
4.6%
5.3%
0.5%
1.7%
2.1%
12.3%
4.0%
0.9%
5.9%

0.0%
3.4%
2.5%
2.7%
2.6%
6.2%
2.3%
7.4%
2.8%
2.3%
7.4%
23.2%
4.6%
4.9%
5.7%
1.0%
0.7%
0.2%
5.6%
0.8%
0.0%

0.3%
1.3%
5.2%
6.7%
0.6%
3.8%
3.4%
3.3%
2.5%
0.4%
4.7%
22.1%
4.4%
10.2%
6.4%
0.7%
0.0%
0.0%
6.8%
3.7%
0.0%

2.4%
0.9%
1.6%
3.5%
1.8%
8.1%
2.4%
4.2%
1.9%
1.4%
8.1%
20.4%
3.6%
5.7%
2.1%
4.2%
1.1%
0.3%
7.1%
1.1%
2.0%

2.4%
2.3%
2.6%
2.3%
1.6%
9.6%
2.8%
4.4%
2.2%
2.4%
5.0%
15.8%
2.2%
9.3%
0.3%
0.9%
1.7%
13.0%
4.0%
1.5%
0.0%

3.4%
1.2%
4.3%
3.6%
1.8%
9.0%
2.1%
4.0%
1.8%
4.4%
6.6%
17.9%
3.4%
6.7%
0.4%
1.3%
1.1%
3.9%
4.9%
1.2%
2.6%

0.0%
1.9%
2.6%
1.9%
2.7%
9.9%
3.1%
4.0%
2.5%
1.5%
6.7%
22.1%
4.9%
7.3%
0.2%
2.1%
1.3%
7.9%
8.6%
0.5%
0.1%

0.0%
2.4%
2.6%
2.8%
3.3%
12.0%
3.1%
3.3%
1.9%
2.6%
5.8%
24.0%
5.6%
5.0%
0.2%
2.6%
1.9%
7.6%
3.5%
1.1%
0.0%

0.0%
1.2%
1.9%
1.6%
3.0%
10.6%
3.1%
4.3%
1.8%
2.0%
5.1%
24.2%
4.3%
6.1%
0.6%
4.4%
1.0%
6.7%
4.5%
1.3%
0.0%

2.8%

1.5%

0.7%

1.2%

1.0%

1.6%

0.0%

0.5%

0.3%

0.2%

Table 3.8 indicates individual abundances for genera across 10 samples. Of note is the
abundance range for Bifidobacterium (0%-13%). None of the samples that were lacking
particular groups appeared to have this made up with higher numbers of another, potentially
related, group.
The variation seen among the ten samples suggested that some bacterial genera may be
affected by age. Table 3.9 highlights calculated Spearman Rank correlation values. We observed
a negative relationship between Bifidobacterium and subject age; and while there are no elderly
individuals in this group and there have not been reports indicating any sort of change in bacterial
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group abundances among young and middle aged adults, studies in elderly individuals indicate
that bacterial groups do differ between younger children and elderly individuals [84].
Interestingly enough, aHLT06 had the highest abundance of Bifidobacterium at 13% and age of
44; aHLT02 being a close partner with 12% abundance however 22 years of age.
Table 3.9 Correlations of Bacterial Genera Abundances and Volunteer Age
Genus
Ruminococcus
Faecalibacterium
Papillibacter
Roseburia
Bifidobacterium
Bacteroides
Lachnospira
Eubacterium
Anaerotruncus
Acetivibrio
Subdoligranulum
Streptococcus
Dorea
Anaerostipes
Clostridium
Coprococcus
Holdemania
Alistipes
Sutterella
Collinsella
Prevotella
Verrucomicrobium

Spearman Rank
Correlation
0.02
-0.31
0.48
0.02
-0.40
0.48
0.29
-0.24
0.14
0.50
0.83
-0.48
-0.62
0.52
0.02
0.07
0.43
0.43
-0.33
-0.31
-0.45
0.14

Table 3.9 shows Spearman Rank Correlation between age and abundance for each genus
(aHLT09 and aHLT10 were omitted from correlation calculation as no age could be obtained for
these two samples). There were no significant values among the correlation (p<0.05).
While it cannot be said that the correlations of these genera are statistically significant,
this may be explained by the fact that volunteers within this group already harbor a well
developed microbiota, some of the older volunteers could be supplementing their diets with
probiotics, and the large gaps between ages of such a small population mask what might
otherwise be a significant observation. Further characterization of these organisms (along with
larger sample size) will aid in an understanding, not only of their role in digestion, but whether
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the trend between abundance and age is real. This trend presents a notable possibility that certain
components of any of these individuals’ diets could contribute to higher numbers of organisms,
for example, the case Bifidobacterium, as there exist many consumer products that are marketed
as probiotic and contain multiple bacterial organisms, Bifidobacterium among them. To more
accurately determine the extent that a decreasing/increasing pattern of bacterial organisms within
a young-middle aged adult group would require a larger sample group with decreased jumps in
age.

Detection of Known Phylo-species Inhabiting the Intestinal Tract
An advantage of using microarrays is the ability to accurately probe at the phylo-species
level. The Microbiota Array interrogates for 775 possible phylo-species, 66 of which have been
characterized and have actual binary names. Out of the 66 characterized phylo-species, 41 were
detected to some degree. All 8 known Bacteroides spp. were found to be present (average range
0.01%-1.02%), along with all of Bifidobacterium (3 species, range 1.02%-1.73%), and
Faecalibacterium (1 species, 1.53%). Known Bifidobacterium species B. catenulatum, and B.
longum displayed the highest variation with respect to abundance, with at least 2-3 samples
containing these genera in amounts of 2.3%-4.3% (data not shown), however as stated above this
is potentially related to consumption of this genus in commercial probiotic products.
It was observed that each individual harbored a unique set of phylo-species, as evidenced
by the occurrence of probesets in each lone sample. This observation led to the idea that there
exists a “core” microbiota, or those phylo-species that are shared among all samples; a
“disposable” microbiota in which phylo-species occur in more than one sample but not all; and
finally a “unique” microbiota that exists in each particular sample. With this sample group it was
seen that out of 775 possible phylo-species, 589 were detected in at least one sample. Of the 589
detected phylo-species, 384 were considered disposable and shared in more than one but not all
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samples; there were 113 phylo-species present in all samples and labeled as the core microbiota,
leaving 89 total phylo-species unique to one of the samples (Figure 3.5). The core microbiota
was made up of 26 genera, mainly Ruminococcus species (37 species, 37% of core), with
Roseburia (19 species, 17% of core), Papillibacter (10 species, 9% of core), and
Faecalibacterium (9 species, 8% of core) making up the rest of the majority. Beyond this there
were 9 genera with 2-4 species among the core (including Bacteroides with 2) and 13 with only 1
species in the core microbiota.

To test how well we sampled the population and whether the core we observed was a
good representation of what might occur in vivo, sample presence and absence data were loaded
into Matlab, and a rarefaction script was applied to determine average core phylo-species across
all ten samples. Rarefaction compares the species richness of multiple samples, especially of
differing sizes. The output of the rarefaction analysis indicates the number of species with
respect to the number of individuals sampled. The curves that are created as a result indicate total
species richness at the point of plateau. The Matlab script accomplishes this by using converted
presence and absence values (P/A into 1/0). The binary data is imported into Matlab in matrix
format (775x10), each row representing a phylo-species and column representing samples. The
script then compares each sample combination out of the total sample population and averages
the number of phylo-species that are present in the total population; then the sample population is
increased by 1 and the script repeats the comparisons. In other words, the first loop of the script
counts how many phylo-species are in each particular sample, then records the average of the
sum. The next loop looks at all pair wise comparisons and again records the average of the sum.
This process repeats, until the population size reaches the actual sample population, in this case
10.
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Results showed that as sample size decreases, the average number of phylo-species that
are shared among samples increases as would be expected (Figure 3.6). While the fit line in
Figure 6 does not truly plateau at 113 phylo-species, this lack of leveling out indicates that there
may be more phylo-species that make up the true human distal gut core.
Figure 3.5 Core, Shared, and Unique Microbiomes of the Adult Distal Colon

Figure 3.5 depicts phylo-species that are shared among all samples (Core), among more
than one but not all (Shared), and those that are specific to each sample (Unique). Each
individual triangle represents a singular sample, the middle donut is indicative of a “meshing” of
phylo-species that appear to be present in more than one occurrence, and the inner circle contains
those phylo-species that are significant enough to populate all samples.
Figure 3.6 Rarefaction of Healthy Adult Volunteers
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Figure 3.6 illustrates the rarefaction curve of healthy adult samples. As sample group size
increases, Core Species decrease and begin to show signs of plateau. Values are average number
of core species, error bars indicate Standard Error. The line represents a polynomial equation fit.
The distribution of unique, shared, and core phylo-species among this sample group may
suggest that subtle differences between people are enough to separate individuals with respect to
the microbiota; however, this cannot be determined nor concretely stated given the size of the
sample group.
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4. DISCUSSION
The development of the microarray and other such culture-independent techniques have
allowed researchers to gain invaluable knowledge into the human intestinal microbiota. Here we
used a custom designed Microbiota Array to assess the intestinal microbiota of 10 healthy adult
volunteers. The benefits of using this technology include the ability to assess quantitatively the
intestinal microbiota, whereas high-throughput sequencing and DGGE lack such ability. Another
advantage of the microarray based approach is the relative ease with which this technology can be
applied to larger populations.

The construction and development of the Microbiota Array

allowed us to quantify accurately the intestinal microbiota of healthy adult volunteers.

The initial analysis showed that Firmicutes was the dominant phylum in all samples,
followed by Actinobacteria, and Bacteroidetes. This observation is in agreement with previous
observations [26] [4], and shows that the higher taxonomical levels are stable and relatively free
from change, further evidenced by looking at the degree of variation among the interrogated
samples. The ratio of Firmicutes and Bacteroidetes shows that the former is approximately 8-9
times more abundant than the latter. This ratio agrees with results seen by Mariat et al., who
observed that healthy adults had 11 times more Firmicutes than Bacteroidetes [34]. The results
seen here are in good concordance with others. Future works would do well to include dietary
intake information to assess further the extent to which diet contributes to the
Firmicutes/Bacteroidetes ratio.

Phylum level analysis is an initial point for examining the

intestinal environment; however, it does not illustrate potential differences among populations.
At the class level we observed that Clostridia was dominant and represented the major
constituent of the Firmicutes phylum. The second most abundant class was Bacteroides and was
the only representative of the Bacteroidetes phylum. Since none of the volunteers had been on
any antibiotics up to 3 months prior to the study, and none had reported any intestinal maladies, it
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can be inferred that the presence of Clostridia is a product of nonpathogenic enteric flora, and not
due to establishment of pathogenic Clostridium species, such as Clostridium difficile which is a
known intestinal pathogen. Members of the class Clostridia aid the human host in fermentation
and degradation of fiber sources in the diet. Bacteroidetes was the second most abundant class in
all ten samples, which is consistent with referenced works and is justified, as this class of bacteria
is beneficial in degrading polysaccharides [11]. It was noted that Actinobacteria was quite
variable across the obtained samples, an interesting result as this class was represented mainly by
the genus Bifidobacterium which is a component of many over-the-counter probiotic products, as
is discussed below. Interestingly, there were cases where the number of detected phylo-species
for a particular class was low even though the overall abundance of the class was high. The
results from the class level are in good concordance with previous studies using fluorescent insitu hybridization [85-87], and indicated to us that the class level gives enough information to
allow insight into the intestinal microbiota, and represents an accurate account of major groups
inhabiting the intestinal tract. The Microbiota Array is able to quantify large communities, which
allowed us to determine the microbiota structure at the genus level as well as enabled us to assess
the presence of known phylo-species. Halting analysis at the class level also hides trends and
differences that potentially hold vital information for proper understanding of intestinal
microbiota relationships.

At the genus level Ruminococcus, a member of Clostridia, was most abundant. In fact,
the top four genera, in accordance with abundance, belonged to Clostridia. Of these four,
Ruminococcus is known to have a substantial number of cellulolytic complexes which are utilized
by species of this genus to attach to plant-derived dietary components and degrade cellulose, a
key component of the plant cell wall structure [44]. This genus of bacteria is also known to be
associated with solid-phase fecal matter. The dominant presence, along with the ability of this
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genus to degrade plant polysaccharides and attach to solid-state fecal content, illustrates that this
genus is a primary degrader in bacterial catabolism of ingested nutrients, supplying byproducts to
other bacterial genera to be used as primary nutrient sources. Faecalibacterium, also a member
of Clostridia, was next abundant. This genus’ ability to utilize acetate and produce butyrate,
suggests that species of this group coordinate the catabolism and utilization of byproducts from
primary degraders to bacteria and colonocytes that use short chain fatty acids (mainly butyrate) as
primary nutrient sources. A species of this genus has also been shown to increase production of
interleukin-10, a potent anti-inflammatory cytokine, further solidifying the necessity of
Faecalibacterium [35].

Bifidobacterium was the major representative of Actinobacteria, however; showed a
tremendous amount of variation between samples. Potential reasons for such variation include a
pattern of decreasing presence with age and consumption of probiotic products such as yogurt or
supplements.

A negative correlation was seen between volunteer age and abundance of

Bifidobacterium and therefore it can be inferred that the degree of variation observed may
indicate a decreasing abundance of this genus with age. A much more detailed analysis into the
roles these genera play in intestinal homeostasis related to metabolism would shed much more
light onto this area of research; unfortunately because of the harsh conditions imposed on these
organisms in trying to cultivate them, many of them remain uncharacterized and thus our focus
remains on those we are able to study. Lastly, it has been shown here that analysis of intestinal
microbiota can be taken down to the genus and species levels. While it is acknowledged here that
analysis at lower taxonomies shows more variations and less consistencies, however; it is
important to include these observations. Furthermore, stopping analysis at the Phylum and Class
levels results in incomplete findings, essentially camouflaging patterns and relationships that are
potentially important.
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The ability of the Microbiota Array to assess accurately large populations
validates it as a valuable tool for studying intestinal microbiota. We observed that species
contribution among all ten samples fit into three microbiome groups; a “core” microbiome in
which species are present in all samples, a “shared” or interchangeable microbiome which can be
defined as species that are present in more than 1 sample yet are not shared among all, and finally
each sample was seen to harbor a “unique” set of phylo-species; a set of phylo-species that were
only seen in each particular sample. To test the accuracy of the core microbiome observed, a
rarefaction script was applied to the samples. The results of the rarefaction agreed with the
observation and also showed that as the sample size increased, the difference between the
calculated core at each population size decreased. From this result it can be inferred that our
observed core microbiome is very close to what might be present in vivo. The core microbiome
was comprised mainly of Ruminococcus (37 species) species, followed by Roseburia (19 species)
and Papillibacter (10 species). This indicates that these genera provide important function to
proper health of the intestinal tract, given that Roseburia and Ruminococcus both contain genes
for catabolizing components of the human diet that would otherwise be indigestible [88] [89]
[90].

What is interesting here is the presence of Papillibacter because there is such a lack of

evidence illustrating this genus’ purpose and function with respect to intestinal health.

The work described here illustrates the ability of the Microbiota Array to quantify
accurately the intestinal microbiota of healthy adult volunteers. We analyzed and compared
different taxonomical levels to better understand how variability and community structure differ
at these lower levels. Previous studies have focused on higher phylogenetic groups, possibly
because of such variability at the genus and phylo-species levels, and while it is not always
advantageous to report such variability, it is important to accurately show true community
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makeup in individuals. The advantage of the Microbiota Array over phylogenetic microarrays
was the use of gDNA as starting material. Previous approaches utilized cDNA synthesized from
RNA, however RNA is more unstable than DNA; therefore it stands to reason that using DNA as
starting material yields results more consistent with actual microbial numbers. Admittedly there
are limitations in this study, mainly the small groups size; and while it would be beneficial to
have much larger sample groups there remains difficulties in acquiring samples from healthy
volunteers. Our ability to assess such low taxonomies is superior to other molecular approaches
because we can combine the results of the Microbiota Aray with other techniques such as NMR
and 16S rRNA arrays. The abilities of the Microbiota Array, along with combination of differing
groups and techniques, will allow us to accurately detect minute changes in intestinal homeostasis
and open venues to better understanding of intestinal relationships. Once we understand the role
of intestinal microbiota in human health and disease, we will be able to detect changes in health
much sooner, resulting in shorter and more productive treatment strategies.
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Appendix A
Wash Buffer A: Non-Stringent Wash Buffer
For 1L:

Reagent
SSPE (20X)
Tween-20 (10%)
Water

Amount (mL)
300
1
699

Filter through 0.2µm filter.
Wash Buffer B: Stringent Wash Buffer
For 1L:

Reagent
MES Buffer (12X)
NaCl (5M)
Tween-20 (10%)
Water

Amount (mL)
83.3
5.2
1
910.5

Filter through 0.2µm filter.
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